Symbol="EVLO"
AssetType="Common Stock"
Name="Evelo Biosciences Inc"
Description="Evelo Biosciences, Inc., a biotechnology company, discovers and develops oral biologics for the treatment of inflammatory diseases and cancer. The company is headquartered in Cambridge, Massachusetts."
CIK="1694665"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="620 MEMORIAL DRIVE, SUITE 200 WEST, CAMBRIDGE, MA, US"
FiscalYearEnd="December"
LatestQuarter="2023-06-30"
MarketCapitalization="243139000"
EBITDA="-102640000"
PERatio="None"
PEGRatio="None"
BookValue="-0.901"
DividendPerShare="0"
DividendYield="0"
EPS="-18.77"
RevenuePerShareTTM="0"
ProfitMargin="0"
OperatingMarginTTM="0"
ReturnOnAssetsTTM="-1.298"
ReturnOnEquityTTM="-62.33"
RevenueTTM="0"
GrossProfitTTM="0"
DilutedEPSTTM="-18.77"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0"
AnalystTargetPrice="15"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="-"
PriceToBookRatio="22.31"
EVToRevenue="-"
EVToEBITDA="-1.714"
Beta="1.573"
num_52WeekHigh="54.4"
num_52WeekLow="1.586"
num_50DayMovingAverage="5.57"
num_200DayMovingAverage="15.67"
SharesOutstanding="18789700"
DividendDate="None"
ExDividendDate="None"
symbol="EVLO"
open="11.80"
high="13.93"
low="11.17"
price="13.31"
volume="397271.00"
latest_trading_day="2023-08-15"
previous_close="12.94"
change="0.37"
change_percent="2.8594%"
aroon_positive_momentum_days="20"
aroon_negative_momentum_days="0"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Buy Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="20"
Volume_recent_avg="7229169"
Change_recent_avg="0.12"
Delta_recent_avg="0.53"
Variance_recent_avg="0.27"
Change_ratio_recent_avg="-3.26"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="positive"
Aroon_change="FALSE"
Aroon_momentum_positive="20"
Aroon_momentum_negative="80"
image_negative_thumbnail_id_1="1104"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0137.jpeg"
image_negative_thumbnail_id_2="1122"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0155.jpeg"
image_neutral_thumbnail_id_1="561"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0038.jpeg"
image_neutral_thumbnail_id_2="567"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0032.jpeg"
image_positive_thumbnail_id_1="959"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0121.jpeg"
image_positive_thumbnail_id_2="974"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0136.jpeg"
image_professor_thumbnail_id_1="1184"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0018.jpeg"
image_professor_thumbnail_id_2="1169"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0003.jpeg"
